Spotlight
Topic
Brand Insights
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Research: New Horizons
Article
Pharmaceutical Executive
Pharmaceutical ExecutivePharmaceutical Executive-03-01-2001
Volume 0
Issue 0
London, UK-Changes to the law on human embryo research could herald a new era for UK biotech research. The government feared its proposals to allow the cloning of embryos as sources for stem cells for research would be thrown out by the House of Lords-where a powerful body of opinion holds that they represent a slippery slope toward reproductive cloning-but the proposals passed by a surprisingly large majority.
Articles in this issue
Research: New Horizons
The Challenge of Prescription Drug Pricing
Earnings: Tough Times Ahead
Antigenics: Quest for a Cure
Outbreak: Anthrax Alarm
Patents: China on the Genome Map
Privacy, Pediatrics, and Policy
Lilly's International Family
Update: Punishment and Reprieve
Biotech: Down for the Count
Shortage: Vaccine Worries
Access: Success Story
Gateway to Japan
Surrounded
Related Videos
Related Content
Fierce Females in the Life Science Space
March 29th 2024Podcast
In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.
